Absorbed dose distributions in patients with bone metastases from hormone refractory prostate cancer treated with Re-186 HEDP

被引：0
|
作者：
Bacelar, A. M. Denis [1 ]
Divoli, A. [2 ]
Chittenden, S. [2 ]
Du, Y. [2 ]
Dearnaley, D. P. [1 ]
O'Sullivan, J. M. [3 ]
Flux, G. D. [2 ]
机构：
[1] Inst Canc Res, Sutton, Surrey, England
[2] Royal Marsden Hosp, Sutton, Surrey, England
[3] Queens Univ Belfast, Belfast City Hosp, Belfast, Antrim, North Ireland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [21] Palliation of painful bone metastasis of hormone refractory prostate cancer by 186-Rhenium (186-Re)
    Özsoy, O
    Bouville, S
    Bieri, S
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 107 - 107
  • [22] DOSE-ESCALATION STUDY OF RE-186 HYDROXYETHYLIDENE DIPHOSPHONATE IN PATIENTS WITH METASTATIC PROSTATE-CANCER
    DEKLERK, JMH
    ZONNENBERG, BA
    SCHIP, ADV
    VANDIJK, A
    HAN, SH
    QUIRIJNEN, JMSP
    BLIJHAM, GH
    VANRIJK, PP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (10): : 1114 - 1120
  • [23] Comparison of PSA measurements and scintigraphy in patients with skeletal metastases from carcinoma of the prostate treated with high activities of Re 186 HEDP.
    McCready, VR
    O'Sullivan, JM
    Dearnaley, DP
    Treleaven, J
    Cook, G
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 412P - 413P
  • [24] Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
    Orsini, Federica
    Guidoccio, Federica
    Mazzarri, Sara
    Mariani, Giuliano
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (08) : 1330 - 1331
  • [25] Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis
    Biersack, Hans-Juergen
    Palmedo, Holger
    Andris, Andrej
    Rogenhofer, Stefan
    Knapp, Furn F.
    Guhlke, Stefan
    Ezziddin, Samer
    Bucerius, Jan
    von Mallek, Dirk
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (11) : 1721 - 1726
  • [26] 188Re HEDP in the treatment of bone metastases generating from prostate cancer.
    Palmedo, H
    Albers, P
    Guhlke, S
    Manka-Waluch, A
    Reinhardt, MJ
    Klemm, E
    Matthies, A
    Joe, A
    Schmaljohann, J
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 160P - 160P
  • [27] 186Re-HEDP for metastatic bone pain in breast cancer patients
    Marnix G. E. H. Lam
    John M. H. de Klerk
    Peter P. van Rijk
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : S162 - S170
  • [28] 186Re_HEDP for metastatic bone pain in breast cancer patients
    Lam, MGEH
    de Klerk, JMH
    van Rijk, PP
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S162 - S170
  • [29] Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer
    Limouris, GS
    Shukla, SK
    Manetou, A
    Kouvaris, I
    Plataniotis, G
    Triantafyllou, N
    Rigas, AV
    Vlahos, L
    ANTICANCER RESEARCH, 1997, 17 (3B) : 1699 - 1704
  • [30] Phase 2 Study of a High Dose of Re-186-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases
    Pirayesh, Elahe
    Amoui, Mahasti
    Mirzaee, Hamid Reza
    Tabei, Faraj
    Rakhsha, Afshin
    Kalantari, Bagher Aziz
    Shafiei, Babak
    Assadi, Majid
    Asli, Isa Neshandar
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2013, 41 (03) : 192 - 196
12345